Rapid experimental SAD phasing and hot-spot identification with halogenated fragments

4-Bromopyrazole and 4-iodopyrazole bind to many small molecule binding hot spots in target proteins. This promiscuous binding enables the use of these compounds for experimental phase determination by single-wavelength anomalous dispersion (SAD). The low cost and safety of the compounds make them excellent choices for addition to the protein crystallographer’s toolkit.

[1]  D. Ringe,et al.  Locating and characterizing binding sites on proteins , 1996, Nature Biotechnology.

[2]  MNDO and DFT Computational Study on the Mechanism of the Oxidation of 1,2-Diphenylhydrazine by Iodine , 2014 .

[3]  Dima Kozakov,et al.  The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins , 2015, Nature Protocols.

[4]  J. Deisenhofer,et al.  'MAD'ly phasing the extracellular domain of the LDL receptor: a medium-sized protein, large tungsten clusters and multiple non-isomorphous crystals. , 2003, Acta crystallographica. Section D, Biological crystallography.

[5]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[6]  Eddy Arnold,et al.  Detecting allosteric sites of HIV-1 reverse transcriptase by X-ray crystallographic fragment screening. , 2013, Journal of medicinal chemistry.

[7]  Z Dauter,et al.  Novel approach to phasing proteins: derivatization by short cryo-soaking with halides. , 2000, Acta crystallographica. Section D, Biological crystallography.

[8]  D. Truhlar,et al.  The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals , 2008 .

[9]  J. Bajorath,et al.  Inhibition of proteinase K by methoxysuccinyl-Ala-Ala-Pro-Ala-chloromethyl ketone. An x-ray study at 2.2-A resolution. , 1994, The Journal of biological chemistry.

[10]  A. Engelman,et al.  Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. , 1994, Science.

[11]  Robert Huber,et al.  Ta6Br122+, a tool for phase determination of large biological assemblies by X-ray crystallography , 1997 .

[12]  Pierangelo Metrangolo,et al.  Halogen bonding in halocarbon-protein complexes: a structural survey. , 2011, Chemical Society reviews.

[13]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[14]  Shuxing Zhang,et al.  Computational prediction of protein hot spot residues. , 2012, Current pharmaceutical design.

[15]  K. Gehring,et al.  Ligand specificity in fragment-based drug design. , 2010, Journal of medicinal chemistry.

[16]  P. Esteves,et al.  Dichloroiodoisocyanuric acid: a new reagent for regioselective coiodination of alkenes and iodination of activated arenes , 2012 .

[17]  L. Christophorou.  Science , 2018, Emerging Dynamics: Science, Energy, Society and Values.

[18]  Eric Westhof,et al.  Halogen bonds in biological molecules. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Betzel,et al.  X‐ray and model‐building studies on the specificity of the active site of proteinase K , 1988, Proteins.

[20]  Steven F. Baker,et al.  Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors. , 2013, ACS chemical biology.

[21]  G. Sheldrick,et al.  The magic triangle goes MAD: experimental phasing with a bromine derivative , 2010, Acta crystallographica. Section D, Biological crystallography.

[22]  S. D. Smith,et al.  Spectroscopy … , 2020, Nature.

[23]  C. Betzel,et al.  Structure of the complex of proteinase K with a substrate analogue hexapeptide inhibitor at 2.2-A resolution. , 1994, The Journal of biological chemistry.

[24]  Joseph D. Bauman,et al.  Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design , 2008, Nucleic acids research.

[25]  J. Rose,et al.  Crystal structure of a bovine neurophysin II dipeptide complex at 2.8 A determined from the single-wavelength anomalous scattering signal of an incorporated iodine atom. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Arnold,et al.  Fragment screening and HIV therapeutics. , 2012, Topics in current chemistry.

[27]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[28]  G. Sheldrick,et al.  A magic triangle for experimental phasing of macromolecules. , 2008, Acta crystallographica. Section D, Biological crystallography.

[29]  Suman Sirimulla,et al.  Halogen Interactions in Protein-Ligand Complexes: Implications of Halogen Bonding for Rational Drug Design , 2013, J. Chem. Inf. Model..

[30]  O. Dym,et al.  Thermal stabilization of the protozoan Entamoeba histolytica alcohol dehydrogenase by a single proline substitution , 2008 .

[31]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[32]  Joseph D. Bauman,et al.  HIV-1 reverse transcriptase complex with DNA and nevirapine reveals nonnucleoside inhibition mechanism , 2012, Nature Structural &Molecular Biology.

[33]  A. Joerger,et al.  Principles and applications of halogen bonding in medicinal chemistry and chemical biology. , 2013, Journal of medicinal chemistry.

[34]  Stefano Forli,et al.  Crystallographic Fragment‐Based Drug Discovery: Use of a Brominated Fragment Library Targeting HIV Protease , 2014, Chemical biology & drug design.

[35]  V. Chiș,et al.  Surface-enhanced Raman and DFT study on zidovudine , 2011 .

[36]  L. Stewart,et al.  Predicting the success of fragment screening by X-ray crystallography. , 2011, Methods in enzymology.

[37]  W A Hendrickson,et al.  Selenomethionyl proteins produced for analysis by multiwavelength anomalous diffraction (MAD): a vehicle for direct determination of three‐dimensional structure. , 1990, The EMBO journal.

[38]  W. Delano.  Unraveling hot spots in binding interfaces: progress and challenges. , 2002, Current opinion in structural biology.

[39]  L. Radom,et al.  Extension of Gaussian‐2 (G2) theory to bromine‐ and iodine‐containing molecules: Use of effective core potentials , 1995 .

[40]  John I. Robinson,et al.  SAD phasing using iodide ions in a high-throughput structural genomics environment , 2011, Journal of Structural and Functional Genomics.

[41]  P. Nissen,et al.  Identifying ligand-binding hot spots in proteins using brominated fragments. , 2013, Acta crystallographica. Section F, Structural biology and crystallization communications.